# Carbonic Anhydrase Antagonism in Subarachnoid Hemorrhage

> **NCT02165644** · PHASE2 · WITHDRAWN · sponsor: **University of Florida**

## Conditions studied

- Acute Cerebrovascular Accident
- Vasospasm

## Interventions

- **DRUG:** Acetazolamide
- **DRUG:** Nimodipine

## Key facts

- **NCT ID:** NCT02165644
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The PI is leaving the University of Florida.
- **Last updated:** 2015-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02165644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02165644, "Carbonic Anhydrase Antagonism in Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02165644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*